Drug-utilisation profiles and COVID-19
Abstract Coronavirus disease 2019 (COVID-19) has substantially challenged healthcare systems worldwide. By investigating population characteristics and prescribing profiles, it is possible to generate hypotheses about the associations between specific drug-utilisation profiles and susceptibility to...
Guardado en:
Autores principales: | Valentina Orlando, Enrico Coscioni, Ilaria Guarino, Sara Mucherino, Alessandro Perrella, Ugo Trama, Giuseppe Limongelli, Enrica Menditto |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/41587489ae0a44ffbcd903a5dbe8c718 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Baseline Drug Treatments as Indicators of Increased Risk of COVID-19 Mortality in Spain and Italy
por: Kevin Bliek-Bueno, et al.
Publicado: (2021) -
Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: a systematic review protocol
por: Valentina Lorenzoni, et al.
Publicado: (2021) -
Ethically utilising COVID-19 host-genomic data
por: Christopher Gyngell, et al.
Publicado: (2021) -
The impact of the COVID-19 pandemic on hospital utilisation in Sierra Leone
por: Justine I Davies, et al.
Publicado: (2021) -
Describing the indirect impact of COVID-19 on healthcare utilisation using syndromic surveillance systems
por: Claire F. Ferraro, et al.
Publicado: (2021)